Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 1.345
+0.030 (2.28%)
Aug 4, 2026, 4:25 PM CET
Hofseth BioCare ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 244.95 | 256.34 | 265.54 | 218.51 | 120.45 | 87.62 | |
Revenue Growth | -7.89% | -3.46% | 21.52% | 81.42% | 37.47% | 26.52% |
Cost of Revenue | 152.81 | 160.97 | 169.55 | 150.69 | 91.93 | 64.52 |
Gross Profit | 92.15 | 95.37 | 95.99 | 67.83 | 28.51 | 23.1 |
Selling, General & Admin | 84.1 | 81.7 | 70.67 | 58.28 | 57.04 | 44.71 |
Depreciation & Amortization Expenses | 40.3 | 39.41 | 39.78 | 36.41 | 30.41 | 29.35 |
Other Operating Expenses | 84.21 | 86.61 | 90.62 | 75.67 | 69.68 | 67.6 |
Total Operating Expenses | 208.61 | 207.72 | 201.07 | 170.35 | 157.13 | 141.66 |
Operating Income | -116.46 | -112.35 | -105.08 | -102.53 | -128.62 | -118.57 |
Interest Income | 19.65 | 15.79 | 1.53 | 9.14 | 4.36 | 3.68 |
Interest Expense | -41.34 | -38.15 | -21.75 | -13.29 | -13.14 | -11.58 |
Total Non-Operating Income (Expense) | -21.69 | -22.36 | -20.22 | -4.16 | -8.77 | -7.9 |
Pretax Income | -138.16 | -134.71 | -125.3 | -106.68 | -137.39 | -126.46 |
Provision for Income Taxes | 0.18 | 0.18 | 0 | 0 | 0 | 0 |
Net Income | -138.33 | -134.88 | -125.3 | -106.68 | -137.39 | -126.46 |
Minority Interest in Earnings | -0 | -0 | -0 | - | - | - |
Net Income to Common | -138.33 | -134.88 | -125.3 | -106.68 | -137.39 | -126.46 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 411 | 411 | 411 | 395 | 375 | 358 |
Shares Outstanding (Diluted) | 419 | 426 | 412 | 395 | 375 | 358 |
Shares Change | 1.68% | 3.44% | 4.26% | 5.43% | 4.72% | 7.25% |
EPS (Basic) | -0.34 | -0.33 | -0.30 | -0.27 | -0.37 | -0.35 |
EPS (Diluted) | -0.34 | -0.33 | -0.30 | -0.27 | -0.37 | -0.35 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -50.14 | -47.54 | -13.84 | -5.43 | -49.19 | -84.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.12 | -0.11 | -0.03 | -0.01 | -0.13 | -0.24 |
Gross Margin | 37.62% | 37.21% | 36.15% | 31.04% | 23.67% | 26.36% |
Operating Margin | -47.54% | -43.83% | -39.57% | -46.92% | -106.78% | -135.32% |
Profit Margin | -56.47% | -52.62% | -47.19% | -48.82% | -114.07% | -144.34% |
FCF Margin | -20.47% | -18.54% | -5.21% | -2.49% | -40.84% | -96.68% |
EBITDA | -76.16 | -72.93 | -65.3 | -66.12 | -98.21 | -89.22 |
EBITDA Margin | -31.09% | -28.45% | -24.59% | -30.26% | -81.53% | -101.83% |
EBIT | -116.46 | -112.35 | -105.08 | -102.53 | -128.62 | -118.57 |
EBIT Margin | -47.54% | -43.83% | -39.57% | -46.92% | -106.78% | -135.32% |
Effective Tax Rate | -0.13% | -0.13% | 0.00% | 0.00% | 0.00% | 0.00% |